Le site du DES d'oncologie de Toulouse

Article

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Hématologie - Publié le 23/06/2019 par Gauthier Glemarec


The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin’s lymphoma has been unclear. We did a prospective randomised clinical trial comparing two reduced-intensity chemotherapy variants with our previous standard regimen. Chemotherapy was followed by PET-guided radiotherapy


Source : Lancet 2012